News

Buy Sun Pharmaceutical Industries Ltd For Target Rs. 2,036 By Choice Broking Ltd Sun Pharma’s Q2FY25 earnings came in slightly below expectations. Revenue reached INR 132.9 bn, reflecting a 9% YoY and 5% QoQ growth, driven primarily by robust performance in the US formulations segment. EBITDA rose significantly by 23.9% YoY and 9.2% QoQ to INR 39.4 bn, with margins expanding by 356 bps YoY and 112 bps QoQ to 29.6%. Adjusted PAT increased 28% YoY and 7.2% QoQ to INR 30.4 bn. The company aims for a goof topline growth this year, alongside a planned increase in R&D...
Buy Sun Pharmaceutical Industries Ltd For Target Rs. 2,036 By Choice Broking Ltd
Buy Sun Pharmaceutical Industries Ltd For Target Rs. 2,036 By Choice Broking Ltd
Source: Choice Broking
2024-11-13 11:11:09 am
India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs Sun Pharmaceuticals, India's largest drugmaker by revenue, reported second-quarter profit above analysts' estimates on Monday, aided by higher demand for its specialty drugs that are used to treat uncommon medical conditions. The Mumbai-based firm's net profit rose 28% to 30.40 billion rupees (nearly $362 million) for the three months ended Sept. 30, beating analysts' estimate of 28.87 billion rupees, according to data compiled by LSEG. The company's high-margin glob...
India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs
India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs
Source: Reuters
2024-10-28 05:32:20 pm
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 46 - Religare Broking Sun Pharmaceutical Industries Ltd * Selling pressure is evident throughout the pharma space and SUNPHARMA trades parallel to same tone. * Recently the stock witnessed breakdown below its rising trend line after a distribution pattern or range consolidation. * Momentum indicators suggest the tone is likely to continue with negative bias & follow-on selling pressure could mount. * Traders are recommended to play the momentum with using PUTs in the mentioned range.   ...
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 46 - Religare Broking
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 46 - Religare Broking
Source: Religare Broking
2024-10-24 10:45:27 am
Punjab CM invites investment proposals from India Inc. in Mumbai  Punjab Chief Minister Bhagwant Singh Mann met several leaders of the India Inc. during his two-day visit to the state and firmed various major investment proposals for his state, government officials said here on Wednesday.   Major corporates like Sun Pharmaceuticals, RPG Group, Sify Technologies and JSW Group were among the companies which expressed their willingness to invest in Punjab or strengthen their existing presence there. Among the top business leaders who called o...
Punjab CM invites investment proposals from India Inc. in Mumbai
Punjab CM invites investment proposals from India Inc. in Mumbai
Source: IANS
2024-08-22 11:37:10 am
Buy Sun Pharma Industries Ltd For Target Rs.1,835 By Choice Broking Ltd Sun Pharma reported Q1FY25 results were marginally below our estimates. The company reported a top line of INR 126.5bn (+6% YoY and +5.6% QoQ), the growth was led by double-digit growth in India and Emerging Markets. EBITDA came at INR 36.1bn (+8.3% YoY and +18.9% QoQ) and the margin expanded to 28.5% (+61bps YoY and +318bps QoQ). PAT at INR 28.36bn grew 24.1% annually and 3.1% sequentially. The company is targeting to achieve high-single-digit topline growth for the year and increase the R&a...
Buy Sun Pharma Industries Ltd For Target Rs.1,835 By Choice Broking Ltd
Buy Sun Pharma Industries Ltd For Target Rs.1,835 By Choice Broking Ltd
Source: Choice Broking Ltd
2024-08-09 03:28:28 pm
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 1830 - Religare Broking Sun Pharmaceutical Industries Ltd. * After a vertical surge, the stock witnessed an intermediate fall and then rebounded sharply resulting into a rounding bottom pattern. * It has recently registered a breakout from the same with strong surge in volumes. * Considering the price action and strength in pharma space, we expect the stock to perform well. * Traders can consider longs in the mentioned range.   Buy Sun Pharmaceutical Industries Ltd CMP 1731....
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 1830 - Religare Broking
Stock of the day : Sun Pharmaceutical Industries Ltd For Target Rs. 1830 - Religare Broking
Source: Religare Broking
2024-08-05 10:40:20 am
Sun Pharmaceutical moves up on reporting 40% rise in Q1 consolidated net profit Sun Pharmaceutical Industries is currently trading at Rs. 1728.50, up by 12.55 points or 0.73% from its previous closing of Rs. 1715.95 on the BSE. The scrip opened at Rs. 1702.00 and has touched a high and low of Rs. 1730.65 and Rs. 1684.25 respectively. So far 87178 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1746.00 on 01-Aug-2024 and a 52 week low of Rs. 1069.00 on 31-Oct-2023. Last one week high and low...
Sun Pharmaceutical moves up on reporting 40% rise in Q1 consolidated net profit
Sun Pharmaceutical moves up on reporting 40% rise in Q1 consolidated net profit
Source: Accord Fintech
2024-08-02 11:32:05 am
Indian drugmaker Sun Pharma posts Q1 profit beat on strong local sales Sun Pharmaceutical, India's largest drugmaker by revenue, reported first-quarter profit above analysts' estimates on Thursday, helped by strong domestic sales. The Mumbai-based company's net profit rose 40% to 28.36 billion rupees ($339 million) in the three months ended June 30, beating analysts' average estimate of 24.78 billion rupees, according to LSEG data. Revenue, however, missed analysts' estimates as generic drugmakers continue to take the hit of lower prici...
Indian drugmaker Sun Pharma posts Q1 profit beat on strong local sales
Indian drugmaker Sun Pharma posts Q1 profit beat on strong local sales
Source: Reuters
2024-08-01 03:49:44 pm
Sun Pharmaceutical climbs on getting USFDA’s nod for LEQSELVI tablets Sun Pharmaceutical Industries is currently trading at Rs. 1704.80, up by 39.60 points or 2.38% from its previous closing of Rs. 1665.20 on the BSE. The scrip opened at Rs. 1675.00 and has touched a high and low of Rs. 1712.00 and Rs. 1665.20 respectively. So far 103105 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,712.00 on 26-Jul-2024 and a 52 week low of Rs. 1069.00 on 31-Oct-2023. Last one week high and l...
Sun Pharmaceutical climbs on getting USFDA’s nod for LEQSELVI tablets
Sun Pharmaceutical climbs on getting USFDA’s nod for LEQSELVI tablets
Source: Accord Fintech
2024-07-26 03:04:23 pm
Sensex trades lower amid profit booking in largecaps India equity indices opened in the red on Friday following profit booking in largecap stocks.  At 9:50 a.m., Sensex was down 510 points or 0.64 per cent at 79,538 and Nifty was down 88 points or 0.36 per cent at 24,214. Broader markets are in an uptrend. On the National Stock Exchange (NSE), 1213 shares are in the green and 1001 shares are in the red. Buying is seen in the smallcap and midcap stocks. The Nifty midcap 100 index is up 60 points or 0.11 per cent at 56,679 and the N...
Sensex trades lower amid profit booking in largecaps
Sensex trades lower amid profit booking in largecaps
Source: IANS
2024-07-05 10:55:23 am
Sun Pharma gains on entering into patent licensing agreement with Takeda Pharmaceutical Sun Pharmaceutical Industries is currently trading at Rs. 1476.95, up by 6.50 points or 0.44% from its previous closing of Rs. 1470.45 on the BSE. The scrip opened at Rs. 1482.95 and has touched a high and low of Rs. 1482.95 and Rs. 1470.45 respectively. So far 5202 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1638.70 on 05-Apr-2024 and a 52 week low of Rs. 977.50 on 23-Jun-2023. Last one week high and low of...
Sun Pharma gains on entering into patent licensing agreement with Takeda Pharmaceutical
Sun Pharma gains on entering into patent licensing agreement with Takeda Pharmaceutical
Source: Accord Fintech
2024-06-21 09:43:08 am
Sun Pharmaceutical Industries declines on getting warning letter from USFDA for Dadra facility Sun Pharmaceutical Industries is currently trading at Rs. 1481.00, down by 23.15 points or 1.54% from its previous closing of Rs. 1504.15 on the BSE. The scrip opened at Rs. 1489.95 and has touched a high and low of Rs. 1489.95 and Rs. 1475.55 respectively. So far 26550 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1638.70 on 05-Apr-2024 and a 52 week low of Rs. 977.50 on 23-Jun-2023. Last one week high and lo...
Sun Pharmaceutical Industries declines on getting warning letter from USFDA for Dadra facility
Sun Pharmaceutical Industries declines on getting warning letter from USFDA for Dadra facility
Source: Accord Fintech
2024-06-20 11:06:35 am
Sun Pharmaceutical Industries trades higher on the BSE Sun Pharmaceutical Industries is currently trading at Rs. 1462.55, up by 9.30 points or 0.64% from its previous closing of Rs. 1453.25 on the BSE. The scrip opened at Rs. 1450.40 and has touched a high and low of Rs. 1476.05 and Rs. 1444.20 respectively. So far 63800 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1638.70 on 05-Apr-2024 and a 52 week low of Rs. 977.50 on 23-Jun-2023. Last one week high and low o...
Sun Pharmaceutical Industries trades higher on the BSE
Sun Pharmaceutical Industries trades higher on the BSE
Source: Accord Fintech
2024-06-04 11:54:20 am
StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result  Below The  views of Prathamesh Masdekar, Research Analyst, StoxBox on Sun Pharma Industries Ltd. Q4FY24 Result   View: - The pharma giant reported strong financial results in Q4FY24, supported by robust performance in the US and domestic markets. The revenue growth was majorly led by the US market in the March quarter, with the global speciality business continuing to increase its share in the overall revenues. The company's two businesses surpassed $...
StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result
StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result
Source: PR Agency
2024-05-23 03:09:31 pm
India`s Sun Pharma beats Q4 profit estimates Indian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on Wednesday, helped by strong performance in its key U.S. and domestic markets. The company's net profit stood at 26.55 billion rupees ($318.9 million) for the three months ended March 31, against analysts' average estimate of 23.68 billion rupees, according to LSEG data.
India`s Sun Pharma beats Q4 profit estimates
India`s Sun Pharma beats Q4 profit estimates
Source: IANS
2024-05-22 03:38:47 pm
Accumulate Sun Pharmaceuticals Ltd for Target Rs. 1,524 - Elara Capital   Stars aligning well Ilumya milestone and Taro help Q3 Sun Pharma (SUNP IN) Q3FY24 EBITDA came in 8% ahead of our estimates,  driven by better margin in the Taro subsidiary and USD 20mn milestone income from the Ilumya partnership. The rest of the business came in line with our expectations. The quarter had little contribution from gRevlimid; we expect the next large chunk from the product in Q4. Robust growth contin...
Accumulate Sun Pharmaceuticals Ltd for Target Rs. 1,524 - Elara Capital
Accumulate Sun Pharmaceuticals Ltd for Target Rs. 1,524 - Elara Capital
Source: Elara Capital
2024-03-13 03:33:41 pm
Sun Pharma trades higher on the BSE Sun Pharmaceutical Industries is currently trading at Rs. 1619.60, up by 12.95 points or 0.81% from its previous closing of Rs. 1606.65 on the BSE. The scrip opened at Rs. 1608.45 and has touched a high and low of Rs. 1627.00 and Rs. 1600.00 respectively. So far 193787 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,627.00 on 11-Mar-2024 and a 52 week low of Rs. 922.55 on 22-May-2023. Last one week high and lo...
Sun Pharma trades higher on the BSE
Sun Pharma trades higher on the BSE
Source: Accord Fintech
2024-03-11 01:45:18 pm
India pharma companies develop versions of Wegovy to get in on weight-loss windfall  Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo Nordisk's wildly in demand Wegovy. With some analysts predicting a weight-loss market reaching $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy's and Lupin -- some of the world's largest generic drugmakers -- all said they have started work on Wegovy versions. ...
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
Source: Reuters
2024-02-22 12:03:24 pm
Stock Picks : Sun Pharma Ltd And NMDC Ltd By ICICI Direc Sun Pharma Ltd Buy Sun Pharma Ltd @ 1528-1530; Target 1547.00; Stop Loss 1519.00     NMDC Ltd Buy NMDC Ltd @ 247.00-247.50; Target 250.50; Stop Loss 245.80     Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631      
Stock Picks : Sun Pharma Ltd And NMDC Ltd By ICICI Direc
Stock Picks : Sun Pharma Ltd And NMDC Ltd By ICICI Direc
Source: ICICI Direct
2024-02-20 10:41:52 am
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,580 - JM Financial Institutional Securities Ltd Sun surprised the Street positively, yet again. Excluding milestone income (USD 20mn) Global specialty sales came in at USD 276mn, up USD 36mn QoQ. This was primarily led by Ilumya, Cequa and Levulan. Among geographical segments, US grew ahead of estimates, India was in line and EM/RoW disappointed on account of weaker currency. EBITDA margin of ~28% was partly driven by milestone income and forex gain adjusting for this margin was 26.1%. Reported PAT was INR 25bn, up 17% YoY (6% beat). Notab...
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,580 - JM Financial Institutional Securities Ltd
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,580 - JM Financial Institutional Securities Ltd
Source: JM Financial Institutional Securities Ltd
2024-02-11 02:08:11 pm
India`s Zydus Lifesciences beats Q3 profit estimates; approves shares buyback Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets. Consolidated net profit for the company rose 27% to 7.90 billion rupees (about $95 million) for the three months ended Dec. 31, beating analysts' average estimate of 6.83 billion rupees, as per LSEG data. Separately, Zydus Lifesciences approved the buyback of shares worth six billion rupees via tender offer r...
India`s Zydus Lifesciences beats Q3 profit estimates; approves shares buyback
India`s Zydus Lifesciences beats Q3 profit estimates; approves shares buyback
Source: Reuters
2024-02-09 02:38:55 pm
Sun Pharmaceutical Industries rises as its arm incorporates wholly-owned subsidiary Sun Pharmaceutical Industries is currently trading at Rs. 1468.50, up by 4.60 points or 0.31% from its previous closing of Rs. 1463.90 on the BSE. The scrip opened at Rs. 1463.50 and has touched a high and low of Rs. 1470.40 and Rs. 1450.00 respectively. So far 13171 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,472.00 on 06-Feb-2024 and a 52 week low of Rs. 922.55 on 22-May-2023. Last one week high and low ...
Sun Pharmaceutical Industries rises as its arm incorporates wholly-owned subsidiary
Sun Pharmaceutical Industries rises as its arm incorporates wholly-owned subsidiary
Source: Accord Fintech
2024-02-06 10:55:59 am
India`s Alembic Pharma beats Q3 profit view on strong domestic, US sales India's Alembic Pharmaceuticals reported a bigger-than-expected third-quarter profit on Monday, driven by higher sales in the domestic and U.S. markets. The generic drugmaker reported a consolidated net profit of 1.80 billion rupees (nearly $22 million) for the three months ending Dec. 31, beating analysts' average estimate of 1.46 billion rupees, as per LSEG data. It had reported a profit of 1.22 billion rupees in the year-ago period. New product launches and easing price erosi...
India`s Alembic Pharma beats Q3 profit view on strong domestic, US sales
India`s Alembic Pharma beats Q3 profit view on strong domestic, US sales
Source: Reuters
2024-02-05 03:25:26 pm
Accumulate Sun Pharmaceuticals Ltd For Target Rs. 1,484 - Elara Capital Elephant set to move Long-awaited Taro buyout manifesting finally We had long awaited Sun Pharmaceuticals’ (SUNP IN) announcement regarding complete buy-out of US-listed Taro subsidiary. For the past many years, this has featured on SUNP's agenda but valuation expectations of the minority shareholders were the key hindrance to its fruition. With the latest development, expect the buyout to go through, with the support of majority of the minority shareholders. The deal values T...
Accumulate Sun Pharmaceuticals Ltd For Target Rs. 1,484 - Elara Capital
Accumulate Sun Pharmaceuticals Ltd For Target Rs. 1,484 - Elara Capital
Source: Elara Capital
2024-01-19 02:23:04 pm
Sun Pharma jumps 3% on announcement of acquiring remaining stake in Taro for Rs 2,891 cr Sun Pharma has entered into a definitive merger agreement with Taro Pharmaceutical Industries pursuant to which Sun Pharma has agreed to acquire all of the outstanding ordinary shares of Taro not currently held by Sun Pharma. Sun Pharma stock is up 3.15 per cent and is the top gainer in Sensex stocks. Taro Pharmaceutical Industries Ltd., is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufactur...
Sun Pharma jumps 3% on announcement of acquiring remaining stake in Taro for Rs 2,891 cr
Sun Pharma jumps 3% on announcement of acquiring remaining stake in Taro for Rs 2,891 cr
Source: IANS
2024-01-18 09:12:51 am
Stock Picks : Reliance Industries Ltd And Sun Pharmaceutical Industries Ltd By ICICI Direct Reliance Industries Ltd Buy Reliance Industries Ltd @2642-2645; Target 2669.00; Stop Loss 2629.30   Sun Pharmaceutical Industries Ltd Buy Sun Pharmaceutical Industries Ltd @1320-1322; Target 1335.00; Stop Loss 1314.40   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Reliance Industries Ltd And Sun Pharmaceutical Industries Ltd By ICICI Direct
Stock Picks : Reliance Industries Ltd And Sun Pharmaceutical Industries Ltd By ICICI Direct
Source: ICICI Direct
2024-01-11 11:21:03 am
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,440 - JM Financial Institutional Securities Ltd Bolder and bigger bets ahead? Sun’s annual operating cash flows of USD 1bn+ and potential access to Taro’s rich cash reserves (if the offer sails through) creates room for bolder and bigger bets (such as Concert), in our view. The key focus area is derma and eye-care in the US. We expect Sun’s specialty sales to sustain double-digit growth momentum given Ilumya’s upward trajectory and Deuruxolitinib launch likely next fiscal. Regulatory headwinds dented US generic s...
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,440 - JM Financial Institutional Securities Ltd
Buy Sun Pharmaceutical Industries Ltd Target Rs.1,440 - JM Financial Institutional Securities Ltd
Source: JM Financial Institutional Securities Ltd
2024-01-05 12:26:29 pm
Sun Pharma clinches $30 million deal for 16.7% stake in US firm India’s Sun Pharmaceuticals Ltd said on Monday that it has entered into agreement to acquire a 16.7 per cent stake in US company Lyndra Therapeutics Inc for $30 million. Lyndra Theraputics, based in Massachusetts, is engaged in the business of developing novel delivery technology for long-acting oral (LAO) therapies. Sun Pharma stated in a regulatory filing that it is making the strategic investment to support development of innovative pharmaceutical delivery technologies and get ...
Sun Pharma clinches $30 million deal for 16.7% stake in US firm
Sun Pharma clinches $30 million deal for 16.7% stake in US firm
Source: IANS
2023-12-19 09:49:45 am
Stock Picks : Reliance Industries Ltd And Sun Pharma Ltd By ICICI Direct Reliance Ltd Buy Reliance Industries Ltd @2489-2492; Target 2514.80; Stop Loss 2478.80   Sun Pharma Ltd Buy Sun Pharma Ltd @1232-1234; Target 1246.00; Stop Loss 1227.40   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Reliance Industries Ltd And Sun Pharma Ltd By ICICI Direct
Stock Picks : Reliance Industries Ltd And Sun Pharma Ltd By ICICI Direct
Source: ICICI Direct
2023-12-18 11:12:12 am
Stock Picks : Sun Pharma And Infosys By ICICI Direct Sun Pharma Buy Sun Pharma @1242-1244; Target 1256.00; Stop Loss 1237.40   Infosys Buy Infosys @1457-1459; Target 1476.00; Stop Loss 1449.80   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Sun Pharma And Infosys By ICICI Direct
Stock Picks : Sun Pharma And Infosys By ICICI Direct
Source: ICICI Direct
2023-12-06 10:53:58 am
Sun Pharma gains as its arm enters into licensing agreement with Aclaris Therapeutics, Inc. Sun Pharmaceutical Industries is currently trading at Rs. 1251.35, up by 11.25 points or 0.91% from its previous closing of Rs. 1240.10 on the BSE. The scrip opened at Rs. 1249.95 and has touched a high and low of Rs. 1254.50 and Rs. 1244.50 respectively. So far 8844 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,254.50 on 06-Dec-2023 and a 52 week low of Rs. 922.55 on 22-May-2023. Last one week high and low ...
Sun Pharma gains as its arm enters into licensing agreement with Aclaris Therapeutics, Inc.
Sun Pharma gains as its arm enters into licensing agreement with Aclaris Therapeutics, Inc.
Source: Accord Fintech
2023-12-06 09:49:29 am
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,310 - Motilal Oswal Financial Services Superior execution drives broad-based revenue growth R&D spending to increase in the coming quarters * Sun Pharma (SUNP) delivered an in-line 2QFY24 financial performance. SUNP garnered healthy growth across specialty as well as branded generics businesses. It continues to implement its initiatives towards: a) an improvement in prescriptions for commercialized specialty products, and b) filing of new products as well as clinical trials for products under development. * We retain our...
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,310 - Motilal Oswal Financial Services
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,310 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services
2023-11-11 09:17:33 am
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,305 - JM Financial SUNP’s 2Q performance was in line with JMFe/ Street estimates. Revenue growth was led by India and RoW markets whereas US performance was muted. While increase in global specialty sales (USD 240mn; +19%YoY), gRevlimid (lower QoQ) and new launches (such as gVyvanse) bring stability to the US business, impact of Halol/ Mohali site issues may keep near-term growth in check. The USFDA has accepted Deuruxolitnib 8mg filing for review - SUNP clarified that the launch could be post approval (k...
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,305 - JM Financial
Buy Sun Pharmaceutical Industries Ltd. For Target Rs. 1,305 - JM Financial
Source: JM Financial Institutional Securities Ltd
2023-11-07 12:34:44 pm
India's top drugmaker Sun Pharma beats Q2 profit view Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a bigger-than-expected rise in second-quarter profit on Wednesday, driven by strong sales in its domestic and U.S. formulation businesses. Consolidated net profit after tax rose to 23.76 billion rupees ($285.37 million) for the quarter ended Sept. 30, from 22.62 billion rupees a year earlier. Analysts, on average, had expected net profit of 23.04 billion rupees, according to LSEG data. Sales from its U....
India's top drugmaker Sun Pharma beats Q2 profit view
India's top drugmaker Sun Pharma beats Q2 profit view
Source: Reuters
2023-11-01 02:52:41 pm
Sun Pharma rises on inking licensing agreement with Zydus Lifesciences for co-marketing of Desidustat Sun Pharmaceutical Industries is currently trading at Rs. 1115.35, up by 4.00 points or 0.36% from its previous closing of Rs. 1111.35 on the BSE. The scrip opened at Rs. 1113.00 and has touched a high and low of Rs. 1116.95 and Rs. 1104.00 respectively. So far 10800 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1169.90 on 03-Aug-2023 and a 52 week low of Rs. 922.55 on 22-May-2023. Last one week high and low o...
Sun Pharma rises on inking licensing agreement with Zydus Lifesciences for co-marketing of Desidustat
Sun Pharma rises on inking licensing agreement with Zydus Lifesciences for co-marketing of Desidustat
Source: Accord Fintech
2023-10-30 11:38:37 am
Stock Picks : Sun Pharmaceutical Industries Ltd And Wipro Ltd By ICICI Direct Sun Pharmaceutical Industries Ltd.Buy Sun Pharmaceutical Industries Ltd @1137-1139; Target 1152.00; Stop Loss 1131.80Wipro LtdBuy Wipro Ltd @391-392; Target 387.00; Stop Loss 394.80Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Sun Pharmaceutical Industries Ltd And Wipro Ltd By ICICI Direct
Stock Picks : Sun Pharmaceutical Industries Ltd And Wipro Ltd By ICICI Direct
Source: ICICI Direct
2023-10-23 10:35:36 am
Stock Picks : Sun Pharmaceutical Industries Ltd And Asian Paints Ltd By ICICI Direct Sun Pharmaceutical Industries LtdBuy Sun Pharmaceutical Industries Ltd @1135-1136; Target 1148.00; Stop Loss 1129.20Asian Paints Ltd Buy Asian Paints Ltd @3096-3098; Target 3064.00; Stop Loss 3116.00Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Sun Pharmaceutical Industries Ltd And Asian Paints Ltd By ICICI Direct
Stock Picks : Sun Pharmaceutical Industries Ltd And Asian Paints Ltd By ICICI Direct
Source: ICICI Direct
2023-10-20 10:39:23 am
Stock Picks : Sun Pharmaceutical Industries Ltd And IndusInd Bank Ltd By ICICI Direct Sun Pharmaceutical Industries Ltd.Buy Sun Pharmaceutical Industries Ltd. @1141-1143; Target 1156.00; Stop Loss 1136.40IndusInd Bank LtdBuy IndusInd Bank Ltd @1459-1461; Target 1478.90; Stop Loss 1450.80Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Sun Pharmaceutical Industries Ltd And IndusInd Bank Ltd By ICICI Direct
Stock Picks : Sun Pharmaceutical Industries Ltd And IndusInd Bank Ltd By ICICI Direct
Source: ICICI Direct
2023-10-16 11:12:08 am
Stock Picks : Sun Pharmaceutical Industries Ltd And Oil and Natural Gas Corporation Ltd By ICICI Direct Sun Pharmaceutical Industries Ltd Buy Sun Pharmaceutical Industries Ltd @1121-1123; Target 1135.00; Stop Loss 1115.80Oil and Natural Gas Corporation LtdBuy Oil and Natural Gas Corporation Ltd @183.50-184.00; Target 181.80; Stop Loss 185.30Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631 
Stock Picks : Sun Pharmaceutical Industries Ltd And Oil and Natural Gas Corporation Ltd By ICICI Direct
Stock Picks : Sun Pharmaceutical Industries Ltd And Oil and Natural Gas Corporation Ltd By ICICI Direct
Source: ICICI Direct
2023-10-05 10:54:50 am
Stock Picks : Sun Pharmaceutical Industries Ltd And NTPC Ltd By ICICI Direct Sun Pharmaceutical Industries LtdBuy Sun Pharmaceutical Industries Ltd @1151-1153; Target 1165.00; Stop Loss 1145.80NTPC LtdBuy NTPC Ltd@242-243.00; Target 245.90; Stop Loss 241.20Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631
Stock Picks : Sun Pharmaceutical Industries Ltd And NTPC Ltd By ICICI Direct
Stock Picks : Sun Pharmaceutical Industries Ltd And NTPC Ltd By ICICI Direct
Source: ICICI Direct
2023-10-03 11:07:20 am
Sun Pharma shines as its arm to acquire balance 25% outstanding shares in Sun Pharma de Mexico Sun Pharmaceutical Industries is currently trading at Rs. 1162.70, up by 30.55 points or 2.70% from its previous closing of Rs. 1132.15 on the BSE.The scrip opened at Rs. 1148.00 and has touched a high and low of Rs. 1167.00 and Rs. 1135.50 respectively. So far 31498 shares were traded on the counter.The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1169.90 on 03-Aug-2023 and a 52 week low of Rs. 921.25 on 29-Sep-2022.Last one week high and low of the scrip stood a...
Sun Pharma shines as its arm to acquire balance 25% outstanding shares in Sun Pharma de Mexico
Sun Pharma shines as its arm to acquire balance 25% outstanding shares in Sun Pharma de Mexico
Source: Accord Fintech
2023-09-29 12:03:50 pm
Pharma industry stocks gain on the BSE amid hopes of revenue growth Stocks related to the pharma industry were trading higher on the BSE, as Crisil in its latest report has said the Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 per cent in current fiscal (FY24) aided by a steady domestic growth and increased exports to regulated markets, even as semi-regulated markets face headwinds. It stated a study of 186 drug makers, which accounted for about half of the Rs 3.7 lakh crore annual revenue of the sector last fiscal, indicates...
Pharma industry stocks gain on the BSE amid hopes of revenue growth
Pharma industry stocks gain on the BSE amid hopes of revenue growth
Source: Accord Fintech
2023-09-12 03:24:55pm